サムスンバイオロジクス、製品カーボンフットプリントシステムで独立検証を取得
This validation is crucial for Samsung Biologics' clients, particularly those operating within or exporting to regions with stringent environmental regulations and growing consumer demand for sustainable products.
Independent validation of Product Carbon Footprint system for enhanced climate transparency.
This validation is crucial for Samsung Biologics' clients, particularly those operating within or exporting to regions with stringent environmental regulations and growing consumer demand for sustainable products. It enables them to accurately assess and report the environmental impact of their biologics, facilitating greener supply chain decisions and potentially offering a competitive advantage in the APAC market. The company's proactive approach to carbon accounting sets a benchmark for the industry.
As a leading biopharmaceutical CDMO in APAC, Samsung Biologics' commitment to climate transparency through validated carbon footprinting directly impacts its regional clients and partners. This initiative aligns with growing ESG expectations across Asia, influencing supply chain sustainability and corporate responsibility standards within the sector.
サムスンバイオロジクスは、製品カーボンフットプリント（PCF）システムにおいて独立検証を取得し、気候変動に関する透明性へのコミットメントを示しました。この検証は、外部専門家との連携を通じて実施され、顧客に対し、製品の正確なカーボンフットプリントデータを提供できるようになります。この取り組みは、バイオ医薬品業界における持続可能なサプライチェーンマネジメントに貢献します。
Where this signal fits in the broader landscape.
https://samsungbiologics.com/media/newsroom/press-releases/samsung-biologics-leads-climate-transparency-with-independent-validation-of-product-carbon-footprint-system
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
ログイン